Ikonisys

Hospitex International to Partner With Allianz Value for First Large-Scale Screening Program Dedicated to Urinary Tract Oncology Diagnostics in Italy - Seite 3

_____________________
¹ Urine24 is a urinary cytological examination, collected with a dedicated non-toxic fixative, performed in standardized monolayer (S-LBC), and reported with the most advanced medical standard "The Paris System 2019". The service includes the shipment and collection of the collection kit at the patient's home, and the sending of the report in digital mode.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240228589475/en/

The Ikonisys Stock at the time of publication of the news with a fall of -1,49 % to 1,320EUR on Frankfurt stock exchange (28. Februar 2024, 08:14 Uhr).